EU R&D keeps active
There has been 'unprecedented development' in terms of the Community's research policy in the last year claims the European Commission's 2002 annual report on technological research and development (RTD) in 2001.
Archives for March 28, 2003
RNA interference - moving from lab to clinic
A collaboration between Cenix BioScience of Germany and the USA's Ambion has been formed to co-develop and market the first commercially-available, human genome-wide library of small interfering RNA sequences. RNA interference is emerging as a potent...
New paradigm for lead optimisation
Pharmaceutical researchers used to begin their evaluation of drug leads by looking at affinity and potency, but a genomics/informatics-based research culture is now growing which is starting to impinge on this classical mode, says a new Cambridge...
Biogen digs into Europe
Biotechnology company Biogen this week celebrated its 25th anniversary by breaking the ground on a large-scale manufacturing facility in Hillerød, Denmark, marking the company's first development phase for the region and a greater presence in Europe.